Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthequity (HQY) EPS (Weighted Average and Diluted) (2016 - 2026)

Healthequity (HQY) has 13 years of EPS (Weighted Average and Diluted) data on record, last reported at $0.59 in Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) rose 883.33% year-over-year to $0.59; the TTM value through Oct 2025 reached $2.18, up 100.0%, while the annual FY2025 figure was $1.09, 70.31% up from the prior year.
  • EPS (Weighted Average and Diluted) reached $0.59 in Q4 2025 per HQY's latest filing, down from $0.68 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.68 in Q3 2025 and bottomed at -$0.39 in Q1 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is $0.14, with a median of $0.06 recorded in 2021.
  • Peak YoY movement for EPS (Weighted Average and Diluted): tumbled 2365.24% in 2021, then soared 12220.86% in 2024.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.06 in 2021, then skyrocketed by 66.67% to -$0.02 in 2022, then surged by 950.0% to $0.17 in 2023, then plummeted by 64.71% to $0.06 in 2024, then skyrocketed by 883.33% to $0.59 in 2025.
  • Per Business Quant database, its latest 3 readings for EPS (Weighted Average and Diluted) were $0.59 in Q4 2025, $0.68 in Q3 2025, and $0.61 in Q2 2025.